Here’s what you should know:
1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.
2. Motus does not yet have a reimbursement code for the Pure-Vu system, and thus needs the public offering to raises funds for further clinical trials.
3. Motus will trade under the symbol MOTS.
More articles on gastroenterology:
Physicians Endoscopy, Exact Sciences & more — 6 GI company key notes
How Anthem’s new anesthesia policy for cataract surgery will affect ASCs — 5 insights
Dr. Brad Cohen replaces hip of celebrity chef Jeffrey Strauss — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.